Cancer Imaging is the official journal of the International Cancer Imaging Society (ICIS)
Articles
Page 15 of 20
-
Citation: Cancer Imaging 2015 15(Suppl 1):P41
-
Brain gliomas: reporting essentials and treatment response
Citation: Cancer Imaging 2015 15(Suppl 1):O39 -
Ovarian cancer: imaging in treatment selection and planning with FIGO update
Citation: Cancer Imaging 2015 15(Suppl 1):O38 -
Pearls and pitfalls in diagnosing prostate cancer using multiparametric MRI (mpMRI)
Citation: Cancer Imaging 2015 15(Suppl 1):P37 -
Chemo cured the cancer: what about the patient?
Citation: Cancer Imaging 2015 15(Suppl 1):O35 -
Fertility preservation in gynaecologic malignancy: imaging role in treatment planning
Citation: Cancer Imaging 2015 15(Suppl 1):P35 -
Imaging and cancer survivorship: challenges and changing concepts
Citation: Cancer Imaging 2015 15(Suppl 1):O33 -
Tractography of the prostatic neurovascular bundles: technique and interpretation
Citation: Cancer Imaging 2015 15(Suppl 1):P33 -
PET/MR imaging: current status and future direction
Citation: Cancer Imaging 2015 15(Suppl 1):O32 -
MR guided focused ultrasound
Citation: Cancer Imaging 2015 15(Suppl 1):O31 -
RECIST criteria: our experience in daily practice
Citation: Cancer Imaging 2015 15(Suppl 1):P31 -
Ablation for metastatic lung cancer
Citation: Cancer Imaging 2015 15(Suppl 1):O29 -
Reducing error: benign abnormalities mimicking malignancy when reporting scans of patients with known malignancy
Citation: Cancer Imaging 2015 15(Suppl 1):P29 -
Hepatic lesions
Citation: Cancer Imaging 2015 15(Suppl 1):O28 -
Orbital tumours
Citation: Cancer Imaging 2015 15(Suppl 1):O27 -
Factors on patency periods of subcutaneous central venous port: long-term results of 1,408 patients
Citation: Cancer Imaging 2015 15(Suppl 1):P27 -
MRI assessment of treatment response
Citation: Cancer Imaging 2015 15(Suppl 1):O26 -
Salivary glands and lymph nodes
Citation: Cancer Imaging 2015 15(Suppl 1):O25 -
Effects of body composition as measured by CT on clinical outcomes in patients with oesophageal cancer
Citation: Cancer Imaging 2015 15(Suppl 1):P25 -
Liver and pancreas
Citation: Cancer Imaging 2015 15(Suppl 1):O24 -
Lung and pleura
Citation: Cancer Imaging 2015 15(Suppl 1):O23 -
Imaging the Ancients
Citation: Cancer Imaging 2015 15(Suppl 1):O21 -
Ultrasound with microbubbles
Citation: Cancer Imaging 2015 15(Suppl 1):O19 -
MRI with hepatobiliary contrast
Citation: Cancer Imaging 2015 15(Suppl 1):O18 -
Microbubbles: from cancer detection to theranostics
Citation: Cancer Imaging 2015 15(Suppl 1):O17 -
Theranostics: radionuclide imaging and therapy in neuroendocrine tumours
Citation: Cancer Imaging 2015 15(Suppl 1):O16 -
PET/CT imaging in prostate cancer
Citation: Cancer Imaging 2015 15(Suppl 1):O15 -
Lung cancer screening: 360 degree review
Citation: Cancer Imaging 2015 15(Suppl 1):O13 -
Small renal masses
Citation: Cancer Imaging 2015 15(Suppl 1):O12 -
Management of splenic “incidentalomas” found on ultrasound and computed tomography
Citation: Cancer Imaging 2015 15(Suppl 1):O11 -
Small bowel masses
Citation: Cancer Imaging 2015 15(Suppl 1):O10 -
Translating imaging biomarkers into clinical practice
Citation: Cancer Imaging 2015 15(Suppl 1):O9 -
Augmented reality: 3D image-guided surgery
Citation: Cancer Imaging 2015 15(Suppl 1):O8 -
Target versus non-target lesions in determining disease progression: analysis of 545 patients
Citation: Cancer Imaging 2015 15(Suppl 1):S8 -
Using structured reporting templates in staging pancreatic malignancies
Citation: Cancer Imaging 2015 15(Suppl 1):O7 -
Characterisation of hepatobiliary lesions in an African referral hospital: initial MDCT dose challenges
Citation: Cancer Imaging 2015 15(Suppl 1):P7 -
Comparison of functional imaging in multiple myeloma patients: Indication for hybrid-imaging with PET/MRI?
Citation: Cancer Imaging 2015 15(Suppl 1):S6 -
Imaging of the pancreas: state of the art
Citation: Cancer Imaging 2015 15(Suppl 1):O5 -
Role of MRI in evaluation of small bowel disease
Citation: Cancer Imaging 2015 15(Suppl 1):P5 -
US perspective
Citation: Cancer Imaging 2015 15(Suppl 1):O3 -
Increase in lesion enhancement on gadoxetic acid enhanced MRI is associated with complete response to neoadjuvant chemotherapy in colorectal liver metastases
Citation: Cancer Imaging 2015 15(Suppl 1):P3 -
Advanced abdominal imaging with dual energy CT is feasible without increasing radiation dose
Citation: Cancer Imaging 2015 15(Suppl 1):P1 -
Approximation of head and neck cancer volumes in contrast enhanced CT
Tumor volume may serve as a predictor of response to radiochemotherapy (RCT) in head and neck squamous cell carcinoma (HNSCC). Computer assisted tumor volumetry requires time-consuming slice-by-slice manual or...
Citation: Cancer Imaging 2015 15:16 -
FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma
Metastatic renal cell carcinoma has a poor prognosis and an intrinsic resistance to standard treatment. Sunitinib is an oral receptor tyrosine kinase inhibitor that has been used as a first-line targeted thera...
Citation: Cancer Imaging 2015 15:15 -
The presurgical T staging of non-small cell lung cancer: efficacy comparison of 64-MDCT and 3.0 T MRI
Lung cancer has been the main concern of the cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) is reported the most common subtype of lung cancer. Initial staging of NSCLC is highly associate...
Citation: Cancer Imaging 2015 15:14 -
Primary hepatic neuroendocrine tumors: comparing CT and MRI features with pathology
Primary hepatic neuroendocrine tumors (PHNET) are extremely rare and difficult to distinguish from primary and metastatic liver cancers since PHNETs blood supply comes from the liver artery. This study aims to...
Citation: Cancer Imaging 2015 15:13 -
Semi-automated segmentation of pre-operative low grade gliomas in magnetic resonance imaging
Segmentation of pre-operative low-grade gliomas (LGGs) from magnetic resonance imaging is a crucial step for studying imaging biomarkers. However, segmentation of LGGs is particularly challenging because they ...
Citation: Cancer Imaging 2015 15:12 -
Diagnostic value of 18F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA
The diagnostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) as the first imaging approach in the evaluation of rising carcinoembryonic antigen (CEA) is not cle...
Citation: Cancer Imaging 2015 15:11 -
Multi-modal imaging of tumor cellularity and Tryptophan metabolism in human Gliomas
To assess gliomas using image-based estimation of cellularity, we utilized isotropic diffusion spectrum imaging (IDSI) on clinically feasible diffusion tensor imaging (DTI) and compared it with amino acid upta...
Citation: Cancer Imaging 2015 15:10 -
STatistically Assigned Response Criteria in Solid Tumors (STARCIST)
Several reproducibility studies have established good test-retest reliability of FDG-PET in various oncology settings. However, these studies are based on relatively short inter-scan periods of 1–3 days while,...
Citation: Cancer Imaging 2015 15:9
Official journal of
Follow
Annual Journal Metrics
-
2022 Citation Impact
4.9 - 2-year Impact Factor
4.7 - 5-year Impact Factor
1.636 - SNIP (Source Normalized Impact per Paper)
1.231 - SJR (SCImago Journal Rank)2023 Speed
13 days submission to first editorial decision for all manuscripts (Median)
123 days submission to accept (Median)2023 Usage
1,045,188 downloads
349 Altmetric mentions